Research Decoder: Remyelination versus Neuroprotection
Two words that I often see used interchangeably are remyelination and neuroprotection. Both processes are part of the body’s innate repair and damage…
Research Decoder: Negative Results
In scientific research, negative results can get a bad rap. What exactly do I mean when I say “negative results”? At its core,…
Action to end MS: Part II
Developing effective therapies for progressive multiple sclerosis, a debilitating form of MS that has eluded successful treatment breakthroughs, represents one of the greatest…
The International Progressive MS Alliance scientific meeting: Connecting to end Progressive MS
Last week, I set out for the historic city of Boston to attend the second scientific meeting of the International Progressive Multiple Sclerosis…
Action to end MS: Part I
Two questions I often hear from people living with multiple sclerosis are “Why does research take so long ?” and “How close are…
Research Decoder: Risk Factors
Although there is no single cause for multiple sclerosis, one priority in research is to identify different risk factors associated with MS. A…
Can drinking coffee protect against MS?
I’ll be the first to admit that I can’t start the day without a nice, strong cup o’ joe (or two). Some interesting…
Research Decoder: Clinical Trials
There’s a lot of buzz in the world of research and in the media about clinical trials. Indeed, just a few weeks ago…
Research Decoder: Incidence versus Prevalence
The world of research is brimming with fancy words and complex ideas, and trying to unscramble scientific lingo can at times be a…
MESCAMS: A recap and what’s next?
On January 29, I was pleased to be part of an exciting announcement made by the MS Society to fund a $4.2 million…